PharmaJet’s Current Partnerships (Pre-Clinical Studies and Clinical Trials):
Infectious Disease
COVID-19
Pre-Clinical Studies
DNA (12)
RNA (2)
Phase 1 Clinical Studies
DNA (6)
- BioNet Asia COVIGEN
- DIOSynVax
- Scancell COVIDITY
RNA (1)
Phase 2 Clinical Studies
DNA (1)
- Vaccibody VB D-01
Phase 3 Clinical Studies
DNA (1)
- Zydus Cadila ZyCoV-D
INFLUENZA
Pre-Clinical Studies
DNA (4)
- Influenza
- Pandemic Influenza
- Swine Influenza
Phase 1 Clinical Studies
DNA (1)
- NIH VRC 316 (Influenza)
Phase 2 Clinical Studies
Phase 3 Clinical Studies
HIV/SIV
Pre-Clinical Studies
DNA (3)
- HIV
- SIV
Phase 1 Clinical Studies
DNA (3)
- INSERM/EuroVacc (HIV)
- Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 2 Clinical Studies
Phase 3 Clinical Studies
ARBOVIRUSES
Pre-Clinical Studies
DNA (4)
- Crimean Congo
- Hemhorragic Fever
- VEEV
- Yellow fever
- Zika
Phase 1 Clinical Studies
Phase 2 Clinical Studies
DNA (1)
- NIH VRC 705 (Zika)
Phase 3 Clinical Studies
HANTAVIRUSES
Pre-Clinical Studies
DNA (1)
- Hantaviruses
Phase 1 Clinical Studies
DNA (1)
- USAMRIID CCHMC (Andes Virus)
Phase 2 Clinical Studies
DNA (1)
- USAMRIID WRAIR (Hantaan/Puumala)
Phase 3 Clinical Studies
OTHER VIRUSES
Pre-Clinical Studies
DNA (3)
RNA (1)
- Hepatitis B
- Marburg Virus
- PRRSV
- Smallpox
Phase 1 Clinical Studies
Phase 2 Clinical Studies
Phase 3 Clinical Studies
Therapeutics
CANCER
Pre-Clinical Studies
DNA (3)
- Canine Cancer
- Multiple Cancers
Phase 1 Clinical Studies
DNA (5)
- Duke University (Breast Cancer)
- Invectys (Therapeutic Cancer)
- MD Anderson (Lymphoma)
Phase 2 Clinical Studies
DNA (5)
- Evaxion EVX-02-001 (Melanoma)
- Invectys (Leukemia)
- Vaccibody VB C-02 (HPV)
- Vaccibody VB N-01 (Neoantigen)
- Vaccibody VB N-02 (Neoantigen)
RNA (1)
- Ludwig/CureVac/BI (Lung Cancer)
Phase 3 Clinical Studies
AUTOIMMUNE
Pre-Clinical Studies
DNA (1)
- Alzheimers
Phase 1 Clinical Studies
DNA (2)
- Alzheimers
- Vitiligo
Phase 2 Clinical Studies
Phase 3 Clinical Studies
Other Applications
VARIOUS INDICATIONS
Pre-Clinical Studies
DNA Platform (multiple)
mRNA Vaccines (multiple)
Other Injectables (multiple)
Phase 1 Clinical Studies
Phase 2 Clinical Studies
Phase 3 Clinical Studies